• Can these lessons be applied to addressing these issues as applied to communication disorders?
Modes of Inheritance 
International HapMap Project
• Conducted from 2003 -2005 • The HapMap is a catalog of linked genetic variants that occur as part of haplotypes.
• Haplotypes were examined to determine how they are distributed within and among different populations of the world.
• Many haplotypes have been found which contain DNA variants that are useful in identifying disease-causing genes.
The International HapMap Project: Ethical, Social, and Cultural Issues
• The goal of the HapMap project was to develop a resource to facilitate future studies that relate human genetic variation to health and disease.
• Because the HapMap facilitated comparisons among both individuals and groups, the ethical issues were especially challenging.
HapMap -Populations Included
• Yoruba (Ibadan, Nigeria)
• Han Chinese (Beijing, China)
• Japanese (Tokyo, Japan)
• Non-medical uses of genetic information:
Ethical Considerations of Genetic Testing
• The availability of genetic tests does not mean that their routine use is appropriate.
• Each genetic test has risks and benefits.
• Information obtained through genetic testing can be empowering.
• Information obtained through genetic testing can disrupt family relationships, can be used as the basis for discrimination or can be psychologically harmful.
Ethical Concerns of Genetic Information
• Additional concerns related to the identification of genes for complex traits: 
Ethical Considerations of Genetic Testing
• Informed Consent:
-The benefits as well as the risks of a genetic test must be fully disclosed.
• Psychological burden • Impact of the information on employment, insurance coverage, and family relationships • These risks are especially applicable to later-onset conditions (heart disease, cancer, Alzheimer's disease, etc.).
• Privacy/Confidentiality:
-Confidentiality of medical records (is privacy possible in the era of electronic databases?) -Who has access to the results of genetic testing (employers, insurance companies, relatives)? -Genetic data are family data.
• Discrimination • HIPAA (Health Insurance Portability and Accountability Act of 1996)
• Federal legislation has been enacted to protect federal workers from genetic discrimination.
• Is adequate genetic counseling provided pre-and post-testing?
• Are primary care physicians likely to know how to interpret genetic tests or have the time to counsel families about using (or not using) the information?
Genetics • Examined recent literature describing research using microarray and other technologies to identify genetic variants associated with autism.
-There was substantial variation and inconsistency in criteria used to determine if genetic variants were causal.
-The language used in scientific publications tended to overestimate the clinical relevance of causal relationships.
-Results tended to be over generalized for the general population.
-All of these factors were thought to lead to media hype and patient misunderstandings about the clinical power of these tests.
Genetic Counseling
• In any genetic testing, pre-and postcounseling by a qualified professional is critical.
• As genetic testing moves into the hands of primary health care providers and direct to consumer, the chance that adequate pre-and post-counseling will occur is diminished.
Ethics and Public Policy
Unfortunately, decisions to introduce genetic tests into clinical practice are based on: • consumer demand • professional practice • legal forces rather than………….
Ethics and Public Policy … a thoughtful evaluation of:
• accuracy and reliability • provisions for consumer and professional education and • public participation in evaluation issues related to testing.
What Often Drives the Use of New Genetic Tests
• Gene discovered
• Gene patent issued/licensing agreement(s) (single or multiple which may increase or decrease competition and pricing)
• Company(ies) develops commercially available genetic test (rarely for rare diseases)
• Company markets genetic test (to doctors and increasingly directly to consumers)
• Test is used in clinical care appropriately and sometimes inappropriately
Evidence-Based Practice
• Also known as outcomes-based or translational research.
• Professionals in the fields of genetics and speech, language and hearing sciences increasingly recognize the importance of the use of evidencebased practice to guide the introduction of new technologies, tests and practice to the clinical realm.
Evidence-Based Practice
An Example from Hereditary Hearing Loss:
• A1555G Mutation in the mitochondrial 12S rRNA gene, MTRNR1 • mutation in combination with exposure to aminoglycosides results in rapid onset of hearing loss • prevalent in Spanish, Chinese and other oriental ethnic groups but has also been found in Caucasians, Greeks, etc.
• testing for this mutation has been clinically available for several years
• The incremental cost-effectiveness of screening for the A1555G variant was examined in a hypothetical population of patients with cystic fibrosis
• This model predicted small improvements in patient outcomes, counteracted by a lack of costeffectiveness and the possibility of worse patient outcomes due to avoidance of antibiotic therapy. Veenstra et al. (2007) . Pharmacogenomic testing to prevent aminoglycosideinduced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes. Genet Med, 9(10): 695-704.
Ethics and Genetics -Examples from Hereditary Hearing Loss
• Mendelian Inheritance 
Middleton et al., 2001
• 644 deaf, 143 hard of hearing and 527 hearing individuals with either a deaf parent or a deaf child • 21% of deaf, 39% of hard of hearing and 49% of hearing said they would consider prenatal diagnosis for deafness • 2% of deaf participants said they would consider a therapeutic abortion of a hearing baby Attitudes Surveys • Brunger et al. (2000) . Parental attitudes toward genetic testing for pediatric deafness. AJHG 67:1621-1625.
-96 hearing parents of deaf children who had undergone genetic testing -the majority had a positive attitude towards genetic testing including prenatal diagnosis, but none said they would use the information to terminate the pregnancy Attitude Surveys • Stern et al. (2002) . Attitudes of deaf and hard of hearing subjects towards genetic testing and prenatal diagnosis of hearing loss. J Med Genet 39:449-453.
• Taneja et al. (2004) . Attitudes of deaf individuals towards genetic testing. Am J Med Genet 130A:17-21.
• Burton et al. (2006) Ryan, Miedzybrodzka, Fraser, Hall (2003) . Genetic information but not termination: pregnant women's attitudes and willingness to pay for carrier screening for deafness genes. J Med Genet 40:e80.
• 104 non-deaf pregnant women from Scotland were surveyed • 72% would want to know if they were a carrier of a deafness gene • 74% would have prenatal diagnosis to determine the fetus' hearing status • 7% would have a termination if the test indicated the baby would be deaf
Conclusions
• Genetic testing, including testing for genes associated with communications disorders, is ethically complex and an individual and societal level.
• Testing for disorders with complex (multifactorial) inheritance brings additional concerns.
• Evidence-based practice is essential to guide the introduction of new technologies, tests and practice to the clinical realm so that benefits are maximized and risks are minimized.
